Trial Profile
Randomized, Single-blinded, Placebo-controlled Study to Evaluate the Safety and Tolerability, the Pulmonary Deposition and Pharmacokinetics of Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (GOLD I - II), Following Inhalation of Ciprofloxacin PulmoSphere Inhalation Powder.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2012
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Adverse reactions
- Sponsors Bayer
- 29 Jan 2010 New trial record